The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Anti Asthma Drugs Market Research Report 2024
Synopsis
Asthma is a chronic lung disease characterized by hyper responsiveness of tracheobronchial smooth muscle to stimuli, resulting in narrowing and inflammation of air tubes, accompanied by increased secretion, swelling and build-up of tissue fluid. Symptoms include tight chest, wheezing, cough and may be limitation of activity due to difficulty in breathing.
The global Anti Asthma Drugs market was valued at US$ 20910 million in 2023 and is anticipated to reach US$ 27190 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Anti Asthma Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti Asthma Drugs.
Report Scope
The Anti Asthma Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti Asthma Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti Asthma Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Merck & Co
AstraZeneca
F. Hoffmann-La Roche
Teva Pharmaceutical
Novartis International
Boehringer Ingelheim
Sunovion Pharmaceuticals
Segment by Type
Bronchodilators
Leukotriene Antagonists
Mast Cell Stabilizers
Corticosteroids
Monoclonal Antibody
Segment by Application
Clinics
Hospitals
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti Asthma Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti Asthma Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Asthma is a chronic lung disease characterized by hyper responsiveness of tracheobronchial smooth muscle to stimuli, resulting in narrowing and inflammation of air tubes, accompanied by increased secretion, swelling and build-up of tissue fluid. Symptoms include tight chest, wheezing, cough and may be limitation of activity due to difficulty in breathing.
The global Anti Asthma Drugs market was valued at US$ 20910 million in 2023 and is anticipated to reach US$ 27190 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Anti Asthma Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti Asthma Drugs.
Report Scope
The Anti Asthma Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti Asthma Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti Asthma Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Merck & Co
AstraZeneca
F. Hoffmann-La Roche
Teva Pharmaceutical
Novartis International
Boehringer Ingelheim
Sunovion Pharmaceuticals
Segment by Type
Bronchodilators
Leukotriene Antagonists
Mast Cell Stabilizers
Corticosteroids
Monoclonal Antibody
Segment by Application
Clinics
Hospitals
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti Asthma Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti Asthma Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Anti Asthma Drugs Market Overview
1.1 Product Overview and Scope of Anti Asthma Drugs
1.2 Anti Asthma Drugs Segment by Type
1.2.1 Global Anti Asthma Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Bronchodilators
1.2.3 Leukotriene Antagonists
1.2.4 Mast Cell Stabilizers
1.2.5 Corticosteroids
1.2.6 Monoclonal Antibody
1.3 Anti Asthma Drugs Segment by Application
1.3.1 Global Anti Asthma Drugs Market Value by Application: (2024-2030)
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Other
1.4 Global Anti Asthma Drugs Market Size Estimates and Forecasts
1.4.1 Global Anti Asthma Drugs Revenue 2019-2030
1.4.2 Global Anti Asthma Drugs Sales 2019-2030
1.4.3 Global Anti Asthma Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Anti Asthma Drugs Market Competition by Manufacturers
2.1 Global Anti Asthma Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Anti Asthma Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Anti Asthma Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Anti Asthma Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti Asthma Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti Asthma Drugs, Product Type & Application
2.7 Anti Asthma Drugs Market Competitive Situation and Trends
2.7.1 Anti Asthma Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti Asthma Drugs Players Market Share by Revenue
2.7.3 Global Anti Asthma Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti Asthma Drugs Retrospective Market Scenario by Region
3.1 Global Anti Asthma Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Anti Asthma Drugs Global Anti Asthma Drugs Sales by Region: 2019-2030
3.2.1 Global Anti Asthma Drugs Sales by Region: 2019-2024
3.2.2 Global Anti Asthma Drugs Sales by Region: 2025-2030
3.3 Global Anti Asthma Drugs Global Anti Asthma Drugs Revenue by Region: 2019-2030
3.3.1 Global Anti Asthma Drugs Revenue by Region: 2019-2024
3.3.2 Global Anti Asthma Drugs Revenue by Region: 2025-2030
3.4 North America Anti Asthma Drugs Market Facts & Figures by Country
3.4.1 North America Anti Asthma Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Anti Asthma Drugs Sales by Country (2019-2030)
3.4.3 North America Anti Asthma Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anti Asthma Drugs Market Facts & Figures by Country
3.5.1 Europe Anti Asthma Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Anti Asthma Drugs Sales by Country (2019-2030)
3.5.3 Europe Anti Asthma Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti Asthma Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Anti Asthma Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Anti Asthma Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Anti Asthma Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anti Asthma Drugs Market Facts & Figures by Country
3.7.1 Latin America Anti Asthma Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Anti Asthma Drugs Sales by Country (2019-2030)
3.7.3 Latin America Anti Asthma Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti Asthma Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti Asthma Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Anti Asthma Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Anti Asthma Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Anti Asthma Drugs Sales by Type (2019-2030)
4.1.1 Global Anti Asthma Drugs Sales by Type (2019-2024)
4.1.2 Global Anti Asthma Drugs Sales by Type (2025-2030)
4.1.3 Global Anti Asthma Drugs Sales Market Share by Type (2019-2030)
4.2 Global Anti Asthma Drugs Revenue by Type (2019-2030)
4.2.1 Global Anti Asthma Drugs Revenue by Type (2019-2024)
4.2.2 Global Anti Asthma Drugs Revenue by Type (2025-2030)
4.2.3 Global Anti Asthma Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Anti Asthma Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Anti Asthma Drugs Sales by Application (2019-2030)
5.1.1 Global Anti Asthma Drugs Sales by Application (2019-2024)
5.1.2 Global Anti Asthma Drugs Sales by Application (2025-2030)
5.1.3 Global Anti Asthma Drugs Sales Market Share by Application (2019-2030)
5.2 Global Anti Asthma Drugs Revenue by Application (2019-2030)
5.2.1 Global Anti Asthma Drugs Revenue by Application (2019-2024)
5.2.2 Global Anti Asthma Drugs Revenue by Application (2025-2030)
5.2.3 Global Anti Asthma Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Anti Asthma Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Anti Asthma Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GlaxoSmithKline Anti Asthma Drugs Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Merck & Co
6.2.1 Merck & Co Corporation Information
6.2.2 Merck & Co Description and Business Overview
6.2.3 Merck & Co Anti Asthma Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck & Co Anti Asthma Drugs Product Portfolio
6.2.5 Merck & Co Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Corporation Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Anti Asthma Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 AstraZeneca Anti Asthma Drugs Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 F. Hoffmann-La Roche
6.4.1 F. Hoffmann-La Roche Corporation Information
6.4.2 F. Hoffmann-La Roche Description and Business Overview
6.4.3 F. Hoffmann-La Roche Anti Asthma Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 F. Hoffmann-La Roche Anti Asthma Drugs Product Portfolio
6.4.5 F. Hoffmann-La Roche Recent Developments/Updates
6.5 Teva Pharmaceutical
6.5.1 Teva Pharmaceutical Corporation Information
6.5.2 Teva Pharmaceutical Description and Business Overview
6.5.3 Teva Pharmaceutical Anti Asthma Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Teva Pharmaceutical Anti Asthma Drugs Product Portfolio
6.5.5 Teva Pharmaceutical Recent Developments/Updates
6.6 Novartis International
6.6.1 Novartis International Corporation Information
6.6.2 Novartis International Description and Business Overview
6.6.3 Novartis International Anti Asthma Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Novartis International Anti Asthma Drugs Product Portfolio
6.6.5 Novartis International Recent Developments/Updates
6.7 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Corporation Information
6.6.2 Boehringer Ingelheim Description and Business Overview
6.6.3 Boehringer Ingelheim Anti Asthma Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Boehringer Ingelheim Anti Asthma Drugs Product Portfolio
6.7.5 Boehringer Ingelheim Recent Developments/Updates
6.8 Sunovion Pharmaceuticals
6.8.1 Sunovion Pharmaceuticals Corporation Information
6.8.2 Sunovion Pharmaceuticals Description and Business Overview
6.8.3 Sunovion Pharmaceuticals Anti Asthma Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sunovion Pharmaceuticals Anti Asthma Drugs Product Portfolio
6.8.5 Sunovion Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti Asthma Drugs Industry Chain Analysis
7.2 Anti Asthma Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti Asthma Drugs Production Mode & Process
7.4 Anti Asthma Drugs Sales and Marketing
7.4.1 Anti Asthma Drugs Sales Channels
7.4.2 Anti Asthma Drugs Distributors
7.5 Anti Asthma Drugs Customers
8 Anti Asthma Drugs Market Dynamics
8.1 Anti Asthma Drugs Industry Trends
8.2 Anti Asthma Drugs Market Drivers
8.3 Anti Asthma Drugs Market Challenges
8.4 Anti Asthma Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
